Govt. issues marketing code for pharmaceutical firms

The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024 on Tuesday, specifying the rules for the use of the words “safe’’ and “new’’ for drugs, and stated that medical representatives must not employ any inducement or subterfuge to gain an interview, and that they must not pay, under any guise, for access to a healthcare professional.

Engagement of the pharmaceutical industry with healthcare professionals for Continuing Medical Education (CME) should only be allowed through a welldefined, transparent, and verifiable set of guidelines, and conduct of such events in foreign locations is prohibited by the uniform code.

Gifting prohibited

Companies or their representatives should not pay cash or monetary grants to any healthcare professional or their family members (both immediate and extended) under any pretext.

Gifting is prohibited by any pharmaceutical company or its agent, that is, distributors, wholesalers, retailers, and so on.

Additionally, no pecuniary advantage or benefit in kind may be offered, supplied or promised to any person qualified to prescribe or supply drugs by any pharmaceutical company or its agent.

The UCPMP is to be circulated for strict compliance, it said.

On drugs, the UCPMP states that promotion of a drug must be consistent with the terms of its marketing approval, and a drug must not be promoted prior to the receipt of its marketing approval from the competent authority.

“Claims for the usefulness of a drug must be based on uptodate evaluation of all available evidence. The word ‘safe’ must not be used without qualification, and it must not be stated categorically that a medicine has no side effects, toxic hazards, or risk of addiction. The word ‘new’ must not be used to describe any drug which has been generally available, or any therapeutic intervention which has been generally promoted in India for more than a year,” the latest rules state.